[Use of new molecules in the treatment of advanced thyroid cancer].
نویسندگان
چکیده
s/. 27. de Groot JW, Zonnenberg BA, van Ufford-Mannesse PQ, de Vries MM, Links TP, Lips CJ, et al. A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab. 2007;92:3466--9. 28. Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, et al. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol. 2008;26:4708--13. 29. Keefe SM, Troxel AB, Rhee S, Puttaswamy K, O’Dwyer PJ, Loevner LA, et al. Phase II trial of sorafenib in patients with advanced thyroid cancer. J Clin Oncol. 2011;29 Suppl [abstract 5562]. 30. Adjei AA, Cohen RB, Franklin W, Morris C, Wilson D, Molina JR, et al. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. J Clin Oncol. 2008;26: 2139--46. 31. Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, et al. A phase II study of gefitinib in patients with advanced thyroid cancer. Thyroid. 2008;18:317--23. 32. Hong DS, Sebti SM, Newman RA, Blaskovich MA, Ye L, Gagel RF, et al. Phase I trial of a combination of the multikinase inhibitor er 385 sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res. 2009;15:7061--8. 33. Wells Jr SA, Gosnell JE, Gagel RF, Moley J, Pfister D, Sosa JA, et al. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol. 2010;28:767--72. 34. Cleary JM, Sadow PM, Randolph GW, Palmer EL, Lynch TP, Nikiforov YE, et al. Neoadjuvant treatment of unresectable medullary thyroid cancer with sunitinib. J Clin Oncol. 2010;28:
منابع مشابه
مروری بر نشانگرهای زیست مولکولیِ سرطان های تیروئید
Thyroid carcinoma is the most common endocrine neoplasia. Like other cancers, early detection of thyroid cancer plays an important role in the treatment and prevention of disease progression. In recent years many efforts have been made to detect molecular biomarkers for early prediction, diagnosis, and prognosis of different types of cancers. This article is a review on different researches abo...
متن کاملMircoRNAs in thyroid cancer
Thyroid cancer, which is known as the most common type of endocrine cancer, has seen a growing prevalence in the last few years. On the other hand, only a small percentage of them are associated with malignancy and most of them are benign tumors. Therefore, the first step in the proper management of this type of cancer is to distinguish malignant tumors from benign ones, and today, we are tryin...
متن کاملتغییرات ژنتیکی و اپی‌ژنتیکی در سرطان تیرویید: مقاله مروری
Thyroid cancer is one of the most common endocrine malignancies and in the last two decades the number of involved people in the world has been increased. Thyroid cancer in Iran is the seventh most common cancer in women and 14th in men. In recent years many achievements regarding to molecular pathogenic factors such as the substantial role of signaling pathways and molecular abnormalities have...
متن کاملAssessment of thyroid cancer risk factors in Kurdistan province
ABSTRACT Background and Aim: Considering the increasing trend of thyroid cancer and increased number of new cases we performed this study to determine the risk factors for thyroid cancer in Kurdistan Province. Materials and Methods: 80 patients and 80 controls were matched and entered into this case-control study from September 2009 to September 2016 in Kurdistan Province. Data were colle...
متن کاملComparison of Absorbed Fraction of Gamma and Beta Rays of I-124 and I-131radio-Isotopes in Thyroid Gland with Monte Carlo Simulation
I131 is a famous radio-iodine isotope in use for diagnosis and treatment of hyper functioning and cancerous thyroid gland. It is a nuclear reactor product; however nuclear reactor may be unavailable in some areas. Replacement by I-124 may be possible, another iodine isotope producible by cyclotron; a system more available than reactor. Here absorbed fraction of Gamma and Beta rays of...
متن کاملComparison of Absorbed Fraction of Gamma and Beta Rays of I-124 and I-131radio-Isotopes in Thyroid Gland with Monte Carlo Simulation
I131 is a famous radio-iodine isotope in use for diagnosis and treatment of hyper functioning and cancerous thyroid gland. It is a nuclear reactor product; however nuclear reactor may be unavailable in some areas. Replacement by I-124 may be possible, another iodine isotope producible by cyclotron; a system more available than reactor. Here absorbed fraction of Gamma and Beta rays of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
دوره 58 8 شماره
صفحات -
تاریخ انتشار 2011